IL22 and inflammatory bowel disease: It is now clear that FICZ stimulates the expression of IL-22 by a variety of different immune cells, including ILC3s, both in vitro [21,82,96,97,98], including human intestinal lamina propria mononuclear cells from IBD patients [18], and in experimental animals [18,20,29,98,99].